Bruce J. Kinon, MD

  • 12Articles
  • 33.6KReads
  • 1998–2024Active
  • 50Collaborators
  • 2.5KCitations

About

Bruce J. Kinon, MD, is affiliated with Karuna Therapeutics in Boston, Massachusetts. He has contributed to Psychiatrist.com from 1998 to 2024, authoring 12 articles on topics including schizophrenia, neurology, genetics, psychiatry, and sexual dysfunction. His frequent co-authors include Bruce R. Basson, Julie A. Gilmore, Gary D. Tollefson, Haya Ascher-Svanum, and Virginia L. Stauffer.

Publications

JCP
Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia
Narrative Review

Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia

August 19, 2024

While the pathophysiology of schizophrenia is complex, treatments with novel pharmacological actions that target these systems are of interest as adjunctive treatment for schizophrenia.
, , , et al
JCP
Original Research

Determinants of Antipsychotic Response in Schizophrenia: Implications for Practice and Future Clinical Trials

April 15, 2014

, , , et al
JCP
Article

New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting: A Great Opportunity for Early Career Psychiatrists

April 15, 2012

, , , et al
JCP
Original Research

Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone

July 12, 2011

, , , et al
JCP
Original Research

Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response

June 2, 2009

, , , et al
JCP
Original Research

Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study

October 31, 2008

, , , et al
JCP
Original Research

Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone

April 1, 2001

, , , et al
JCP
Original Research

Long-Term Olanzapine Treatment: Weight Change and Weight-Related Health Factors in Schizophrenia

February 2, 2001

, , , et al
JCP
Article

Effective Resolution With Olanzapine of Acute Presentation of Behavioral Agitation and Positive Psychotic Symptoms in Schizophrenia

February 1, 2001

, , , et al
JCP
Article

Weight Change and Atypical Antipsychotic Treatment in Patients With Schizophrenia

February 1, 2001

, , , et al
JCP
Original Research

Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine

October 31, 2000

, , , et al
JCP
Article

The Routine Use of Atypical Antipsychotic Agents: Maintenance Treatment

April 1, 1998

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe